Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 69 citing articles:

Malaria vaccines since 2000: progress, priorities, products
Patrick E. Duffy, J. Patrick Gorres
npj Vaccines (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 212
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
Angela M. Minassian, Sarah E. Silk, Jordan R. Barrett, et al.
Med (2021) Vol. 2, Iss. 6, pp. 701-719.e19
Open Access | Times Cited: 122
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Sarah E. Silk, Wilmina F. Kalinga, Jo Salkeld, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1105-1117
Open Access | Times Cited: 18
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies
Daniel G. W. Alanine, Doris Quinkert, Rasika Kumarasingha, et al.
Cell (2019) Vol. 178, Iss. 1, pp. 216-228.e21
Open Access | Times Cited: 134
Biomaterials for stem cell engineering and biomanufacturing
Yibo Xu, Chuanxin Chen, Peter B. Hellwarth, et al.
Bioactive Materials (2019) Vol. 4, pp. 366-379
Open Access | Times Cited: 102
Current Challenges in Vaccinology
Richard B. Kennedy, Inna G. Ovsyannikova, Peter Palese, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 73
Heterotypic interactions drive antibody synergy against a malaria vaccine candidate
Robert J. Ragotte, David Pulido, Amelia M. Lias, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
Sarah E. Silk, Wilmina F. Kalinga, Ivanny M. Mtaka, et al.
Med (2023) Vol. 4, Iss. 10, pp. 668-686.e7
Open Access | Times Cited: 27
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype
Jordan R. Barrett, Dimitra Pipini, Nathan Wright, et al.
Cell (2024) Vol. 187, Iss. 18, pp. 4964-4980.e21
Open Access | Times Cited: 14
Vaccine adjuvants for infectious disease in the clinic
Morgan Goetz, Naaz Thotathil, Zongmin Zhao, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 4
Open Access | Times Cited: 11
Targeting Bottlenecks in Malaria Transmission: Antibody‐Epitope Descriptions Guide the Design of Next‐Generation Biomedical Interventions
Randy Yoo, Matthijs M. Jore, Jean‐Philippe Julien
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 1
The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target
Robert J. Ragotte, Matthew K. Higgins, Simon J. Draper
Trends in Parasitology (2020) Vol. 36, Iss. 6, pp. 545-559
Open Access | Times Cited: 63
Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors
Carolyn M. Nielsen, Ane Ogbe, Isabela Pedroza‐Pacheco, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 3, pp. 100207-100207
Open Access | Times Cited: 44
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
Carolyn M. Nielsen, Jordan R. Barrett, Christine Davis, et al.
JCI Insight (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 20
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies
Lloyd D. W. King, David Pulido, Jordan R. Barrett, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101654-101654
Open Access | Times Cited: 6
Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies
Lloyd D. W. King, David Pulido, Jordan R. Barrett, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Barnabas G. Williams, Lloyd D. W. King, David Pulido, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes
Julie Healer, Wilson Wong, Jennifer K. Thompson, et al.
Cellular Microbiology (2019) Vol. 21, Iss. 7
Open Access | Times Cited: 42
Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate Antigens
Joseph J. Illingworth, Daniel G. W. Alanine, Rebecca Brown, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 42
Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases
Lampouguin Yenkoidiok-Douti, Christopher M. Jewell
ACS Biomaterials Science & Engineering (2020) Vol. 6, Iss. 2, pp. 759-778
Open Access | Times Cited: 36
Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21
Carl R. Alving, Mangala Rao, Gary R. Matyas
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children
Hamtandi Magloire Natama, Jo Salkeld, Anyirékun Fabrice Somé, et al.
The Lancet Infectious Diseases (2024)
Open Access | Times Cited: 4
Antibody correlates of risk of clinical malaria in an area of low and unstable malaria transmission in western Kenya
Eliud O. Odhiambo, Kagan A Mellencamp, Bartholomew N. Ondigo, et al.
Malaria Journal (2025) Vol. 24, Iss. 1
Open Access
Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype
Jordan R. Barrett, Dimitra Pipini, Nathan Wright, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
Product safety aspects of plant molecular farming
Johannes F. Buyel
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top